| Name | Title | Contact Details |
|---|
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.
Superior Healthcare Management is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SecureHorizons is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accent On Health At Latham Inc is a Latham, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Grace Management, Inc. is a nationally recognized leader in delivering senior living management service. Grace Management was established in 1984 and has built a reputation not only as a business leader in the senior living industry, but also as having developed a family-driven approach. Grace Management communities include independent living, cottage and estate homes, assisted living, and memory care that offer a diverse array of services and amenities catered to the individual.